| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 24,249 | 24,601 | 25,057 | 24,404 | | Cost of Revenue |
-
|
-
|
-
|
-
| | | Gross Profit | 24,249 | 24,601 | 25,057 | 24,404 | | | Operating Expenses | | Research Development | 23,219 | 38,615 | 25,321 | 24,943 | | Selling General and Administrative | 10,680 | 8,398 | 7,716 | 7,274 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (9,650) | (22,412) | (7,980) | (7,813) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 1,026 | 1,434 | 2,226 | 2,608 | | Earnings Before Interest And Taxes | (9,760) | (21,794) | (7,224) | (9,080) | | Interest Expense |
-
|
-
|
-
| 256 | | Income Before Tax | (9,760) | (21,794) | (7,224) | (9,336) | | Income Tax Expense | (552) | 908 | 665 | 56 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (12,630) | (22,702) | (7,889) | (9,392) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (9,208) | (22,702) | (7,889) | (9,392) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($9,208) | ($22,702) | ($7,889) | ($9,392) |
|
0.63% Nasdaq 
0.03%
Income Statement
